Full Source List

Source

1.Cho HH, Kim MR, Kim JH. Outpatient multimodality management of large submucosal myomas using transvaginal radiofrequency myolysis. J Minim Invasive Gynecol. 2014 Nov-Dec;21(6):1049-54. doi: 10.1016/j.jmig.2014.04.019. Epub 2014 May 29. PMID: 24882599.

2.Kim CH, Kim SR, Lee HA, Kim SH, Chae HD, Kang BM. Transvaginal ultrasound-guided radiofrequency myolysis for uterine myomas. Hum Reprod. 2011 Mar;26(3):559-63. doi: 10.1093/humrep/deq366. Epub 2011 Jan 7. PMID: 21216788.

3.Young Lee, Hyun Hee Cho, Jin Hong Kim, Jang Heub Kim, Mee Ran Kim, Young Ok Lew, and SungJin Hwang. Radiofrequency Thermal Ablation of Submucosal Leiomyoma: A Preliminary Report on Health, Symptom, and Quality of Life Outcomes. Journal of Gynecologic Surgery.Dec 2010.227 231.http://doi.org/10.1089/gyn.2009.0101

4.Yin G, Chen M, Yang S, Li J, Zhu T, Zhao X. Treatment of uterine myomas by radiofrequency thermal ablation: a 10-year retrospective cohort study. Reprod Sci. 2015;22(5):609-614. doi:10.1177/1933719114556481

5.Bradley, Linda D et al. “Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies.” Journal of laparoendoscopic & advanced surgical techniques. Part A vol. 29,12 (2019): 1507-1517. doi:10.1089/lap.2019.0550

6.Cho HH, Kim JH, Kim MR. Transvaginal radiofrequency thermal ablation: a day-care approach to symptomatic uterine myomas. Aust N Z J Obstet Gynaecol. 2008 Jun;48(3):296-301. doi: 10.1111/j.1479-828X.2008.00855.x. PMID: 18532962.

7.Ulin M, Ali M, Chaudhry ZT, Al-Hendy A, Yang Q. Uterine fibroids in menopause and perimenopause. Menopause. 2020 Feb;27(2):238-242. doi: 10.1097/GME.0000000000001438. PMID: 31834160; PMCID: PMC6994343.

8.Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. 2012 Mar 26;12:6. doi: 10.1186/1472-6874-12-6. PMID: 22448610; PMCID: PMC3342149.

9.Yin G, Chen M, Yang S, Li J, Zhu T, Zhao X. Treatment of uterine myomas by radiofrequency thermal ablation: a 10-year retrospective cohort study. Reprod Sci. 2015 May;22(5):609-14. doi: 10.1177/1933719114556481. Epub 2014 Oct 29. PMID: 25355802; PMCID: PMC4519765.

10.https://www.mayoclinic.org/diseases-conditions/uterine-fibroids/symptoms-causes/syc-20354288

11.https://www.verywellhealth.com/myoma-5190866

LEGAL DISCLAIMER
Last Updated August 9, 2022

IMPORTANT SAFETY INFORMATION

The MYOBLATE™ electrodes are CE-certified and indicated for the treatment of uterine fibroids. The content herein is solely for informational and educational purposes and should not be construed as medical or health advice. While the MYOBLATE™ Uterine Fibroid RFA Procedure may offer substantial benefits to many patients, it is not universally applicable, and individual outcomes may vary. Please contact your medical professional for specific advice regarding the potential benefits, risks, and suitability of this treatment in your specific case.

LEGAL DISCLAIMER

This information is not intended as an offer for sale or promotion in jurisdictions where such activities are restricted. The imagery used in this material is for illustrative purposes only, featuring models, and should not be interpreted as an endorsement or representation of typical patient outcomes. For more details about information provided on this Site, please click here.

FULL SOURCE LIST